Appelhans Dannielle - Insider Non-Derivative Transactions at Rubius Therapeutics, Inc. (RUBY) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Feb 24, 2023, Appelhans Dannielle's relationship to Rubius Therapeutics, Inc. (RUBY) is Officer (CEO and President), and currently has 0 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other RUBY insiders.
Data Source: SEC.
Appelhans Dannielle - Insider Non-Derivative Transactions of RUBY Common Stock
Appelhans Dannielle - Insider Non-Derivative Transactions at RUBY
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Feb 25, 2023 | Sell -- (Common Stock) | 10385 | 0.13 | 0 |
| Feb 2, 2023 | Sell -- (Common Stock) | 3878 | 0.25 | 10385 |
| Feb 1, 2023 | M -- (Common Stock) | 7500 | 0 | 14263 |